cefuroxime has been researched along with Leukemia in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most common type of infection was pneumonia (48% alone; 72% with other sites involved), which accounted for a high fatality rate (15%); the highest rate occurred during septicemia with pneumonia (50%)." | 2.65 | Empiric therapy of infections in hematologic malignancies: a prospective, randomized trial. ( Benini, F; Caramaschi, G; Cetto, GL; Perona, G; Todeschini, G; Vinante, F, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cetto, GL | 1 |
| Todeschini, G | 1 |
| Caramaschi, G | 1 |
| Vinante, F | 1 |
| Benini, F | 1 |
| Perona, G | 1 |
1 trial available for cefuroxime and Leukemia
| Article | Year |
|---|---|
Empiric therapy of infections in hematologic malignancies: a prospective, randomized trial.
Topics: Adolescent; Adult; Aged; Ampicillin; Anemia, Aplastic; Carbenicillin; Cefuroxime; Female; Humans; In | 1983 |